Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Cooperative Centers of Excellence in Hematology (CCEHs)

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Cooperative Centers of Excellence in Hematology (CCEHs) is a national network of cores managed by the National Institutes of Health under the Department of Health and Human Services. This program is designed to support the nonmalignant hematology research community by providing state-of-the-art resources, specialized expertise, enrichment activities, and small pilot and feasibility funding to improve the overall quality of scientific research. The current initiative focuses on the renewal of the CCEH program with a specific emphasis on enhancing strategies to improve transparency, accountability, and the shareability of resources. This forecast, associated with NAICS code 541715, aims to elevate the excellence of the program and is coordinated by Jennifer Norton.

General Info

National CCEHs program funds and supports collaborative nonmalignant hematology research with enhanced transparency.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedSep 29

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health

Office AddressUSA

Contacts

Jennifer Norton

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

The Cooperative Centers of Excellence in Hematology (CCEHs) are a national network of cores that provide state-of-the-art resources and services, expertise, enrichment activities, and small pilot and feasibility (P&F) funding to support and enhance the nonmalignant hematology research community and the quality of its science. The renewal of the CCEH program with enhanced strategies will improve the transparency, accountability, shareability, and overall excellence of the program.

Similar Contracts

Same NAICS industry code

Marine Scientific ResearchThis subcontract for Marine Scientific Research involves providing specialized research and analysis for prime contractors working on Historic England marine protection projects. The primary objective is to investigate the decay and various threats facing significant marine heritage assets to inform conservation and enhancement strategies. The scope of work includes the use of laboratory analysis equipment to examine marine samples. The selected provider will be responsible for delivering technical reports, research papers, and specific conservation recommendations. This opportunity is associated with NAICS code 541715 and was posted on October 12, 2026, with a response deadline of November 13, 2026.

Historic England

POSTED

about 16 hours ago

DEADLINE

in about 1 month

Building America Subject Matter Expert Technical Support

Solicitation # RFP-2026-10245()

Llc - DOE Contractor Alliance For Energy Innovation

POSTED

about 20 hours ago

DEADLINE

in about 1 month

Airborne Advanced Tactical Data Link (ATDL) Engineering Support (C)The Airborne Advanced Tactical Data Link (ATDL) Engineering Support forecast, issued by Niwc Pacific under the Naval Information Warfare Systems, seeks engineering, subject matter expertise, and Best Manufacturing Practices support for Hardware Defined Radio and Software Defined Radio systems. This effort is designed to support U.S. Department of Defense programs and Military Forces, specifically focusing on digital data link systems such as the Joint Tactical Radio System, Multifunctional Information Distribution System, Joint Tactical Information Distribution System, and the Command and Control Processor. The scope of work encompasses a variety of networks, waveforms, and protocols, including Link-16, Soldier Radio Waveform, Tactical Targeting Networking Technology, and other emergent SDR technologies. Performance for this contract is expected to take place in San Diego, with the project falling under NAICS code 541715. Dan Nardi serves as the primary point of contact for this acquisition.

POSTED

DEADLINE

LIPTM00397 - CANES Engineering IPT - IWRP 25-LANT-2814 (C)The LIPTM00397 contract, titled CANES Engineering IPT - IWRP 25-LANT-2814, is a forecast for the CANES NextGen IWRP prototype managed by Naval Information Warfare Systems through Niwc Atlantic. This effort falls under NAICS code 541715 and is scheduled for posting on October 11, 2026. The primary place of performance for this project is located in North Charleston. Administrative oversight for this requirement is handled by Contracting Officer Giancarlo Dumenigo, with Kristopher Garris serving as the secondary point of contact. The project is part of a broader long range acquisition strategy to advance engineering and prototype capabilities for the Navy's next generation of integrated wireless routing and processing.

POSTED

DEADLINE

Modeling & Simulation-28 Contract

Naval Information Warfare Systems

POSTED

DEADLINE

Lead Epidemiologist / Public Health Research FirmThis subcontract opportunity is for a Lead Epidemiologist or Public Health Research Firm to provide scientific leadership and design for a retrospective epidemiological study supporting the County of San Diego Public Health Services. The selected partner will be responsible for developing study protocols, defining geographic exposure zones, and evaluating exposure-response relationships related to chemical pollution impacts. Key requirements for the role include specialized expertise in Trauma-Informed Systems and a deep understanding of Environmental Justice communities. The primary deliverables for this engagement are the Study Protocol and a Final Report. The work will be performed in San Diego, California, under NAICS code 541715. Interested parties must submit their responses by the deadline of October 31, 2026.

County of San Diego

POSTED

DEADLINE

SI Model Development and Training ServicesThe SI Model Development and Training Services subcontract involves the design, training, and fine-tuning of AI and SI models to support video intelligence projects for the Department of Homeland Security ICE. The scope of work includes implementing model explainability, labeling, and human-in-the-loop oversight using data provided by ICE. To avoid vendor lock-in, the contractor must ensure all outputs are non-proprietary and machine-readable, delivering final trained models, model weights, and comprehensive provenance documentation. This opportunity is managed by the Information Technology Division and is based in Washington, DC. Due to the sensitive nature of the work, personnel are required to hold Secret or Top Secret clearances, and the performing entity must possess a DSS Facility Clearance. Interested parties should note the response deadline of October 26, 2026.

Information Technology Division

POSTED

DEADLINE

Mobile Integrated Launch Capability

Solicitation # 26-MDA-12366

The Missile Defense Agency (MDA) is soliciting innovative and cost-efficient alternatives to current C-17 air drop target launches through the Mobile Integrated Launch Capability (MILC) program. The objective is to develop mobile launch platforms capable of deploying short to long-range target missile systems, including ballistic, air-breathing, and maneuvering targets, from various global locations via ground, sea, or air. This effort is structured in two phases: Phase I focuses on detailed design, engagement analysis, and prototype costing with an objective period of three months; Phase II involves prototyping, ground testing, and the delivery of one launch platform for a demonstration launch, with an objective period of twelve months. The solicitation follows a two-step competitive process based on the evaluation of white papers, which are judged on technical merit, innovation, potential utility to agency programs, schedule adherence, and lifecycle cost. Offerors must be registered in the System for Award Management and maintain an active Secret Facility Clearance to handle classified information. Procurement may be executed through Revolutionary Federal Acquisition Regulation (RFO) based contracts or Other Transaction (OT) agreements, the latter of which prioritize commercial industry standards. Submissions must include a detailed program plan, a Rough Order of Magnitude cost estimate, and a full disclosure of any organizational conflicts of interest.

Missile Defense Agency (mda)

POSTED

DEADLINE

in almost 2 years

MTEC Solicitation Summary: Fiscal Year 2026 Multi-Topic Request for Project Proposals

Solicitation # MTEC-26-04-MultiTopic

The Medical Technology Enterprise Consortium (MTEC), in collaboration with the Defense Health Agency, is soliciting project proposals under solicitation MTEC-26-04-MultiTopic for medical prototype technological and knowledge solutions. Authorized under 10 U.S.C. section 4022 and utilizing an Other Transaction Agreement, this effort seeks to modernize medical capabilities to maintain force readiness and soldier lethality in future multi-domain conflicts. The solicitation covers 16 distinct Focus Areas, including behavioral health, physical fitness, wound infection prevention, sepsis treatment, musculoskeletal injury interventions, non-addictive analgesics, blast and blunt impact sensors, and a multisite clinical biomarker platform for lung and kidney failure. Proposals are submitted via a two-stage Enhanced White Paper process, where selected Stage 1 submissions are invited to provide full cost proposals in Stage 2. To be eligible, projects must demonstrate clear military relevance, meet a minimum Knowledge/Technology Readiness Level of 3, and fit the specific definition of a prototype rather than being exploratory. Additionally, solutions must not have been submitted to MTEC within the last two years. While average initial awards range from 2.0 to 3.5 million dollars over a two to three year period, specific funding and performance periods vary by Focus Area. Teaming is encouraged, and successful projects may be eligible for non-competitive follow-on tasks.

Defense Health Agency

POSTED

DEADLINE

Atomically Precise Molecules (APM)

Solicitation # DARPA-PS-26-141

The Defense Advanced Research Projects Agency (DARPA) Multi X Office is soliciting proposals for the Atomically Precise Molecules (APM) program under solicitation DARPA-PS-26-141. The program aims to develop innovative synthesis techniques for programmable precision polymers (PPPs) and nonlinear optical (NLO) materials to overcome performance gaps in optical communications and LiDAR. The primary objective is the creation of scalable, fit-for-purpose materials, culminating in a prototype demonstration of a revolutionary NLO material integrated into a government-provided electro-optic modulator. Research focusing solely on inorganic materials or incremental improvements to the state-of-the-art is specifically excluded. This 36-month effort is structured in two technical phases, with Phase I focusing on developing PPP synthesis capabilities over the first 12 months. Awards will be issued as Other Transaction (OT) for Prototype Agreements under 10 U.S.C. 4022. Key requirements include CMMC Level 2 self-assessment compliance and adherence to a program-specific Controlled Unclassified Information (CUI) guide. Non-US organizations, FFRDCs, UARCs, and government entities are ineligible to serve as prime performers, though FFRDCs and UARCs may participate as subawardees provided they meet specific certification and conflict of interest mitigation requirements. Proposals must be submitted via the Broad Agency Announcement Tool (BAAT) by December 18, 2026. Submissions must include a technical and management volume, a price proposal with a detailed spreadsheet, a Task Description Document, and a schedule of milestones and payments. Evaluation will be based on the technical approach, relevance to the DARPA mission, budget realism, and the capability to transition the technology to military or commercial sectors. Payments are milestone-based and processed through the Wide Area Workflow (WAWF) system.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Lunar Enabling Infrastructure Accelerator (LEIA) -Broad Agency Announcement (BAA) NextSTEP-3 Appendix A - Final Solicitation

Solicitation # 80GRC026R0008

The Lunar Enabling Infrastructure Accelerator (LEIA) is a full and open competition solicitation issued by the NASA Glenn Research Center under the NextSTEP-3 Broad Agency Announcement. The program seeks industry partners to design, develop, and demonstrate prototype systems to mature critical lunar and cislunar infrastructure technologies from lower technology readiness levels toward TRL 5-6. The scope is divided into five technical topics: Vertical Solar Arrays, In-Situ Resource Utilization (ISRU) Oxygen from Regolith Production, Radioisotope Stirling Generators, In-Space Advanced Manufacturing, and Innovative Nanomaterials Production. Awards will be firm-fixed-price contracts with an anticipated total period of performance not exceeding three years, with awards expected in the second quarter of fiscal year 2027. Proposals are evaluated based on a pass/fail assessment of relevance and past experience, followed by a scored evaluation of technical merit, which includes the technical approach, execution strategy, work plan, organizational readiness, personnel qualifications, and risk mitigation. Price and business volumes are reviewed for fairness, reasonableness, and risk but are not numerically scored. Offerors must submit a comprehensive proposal package via NASA's EFSS Box, including a detailed work plan in the form of a Statement of Work, an Organizational Conflicts of Interest plan, and required eligibility certifications. All deliverables must adhere to strict NASA security, cybersecurity, and equipment marking standards, with final inspection and acceptance occurring at the destination.

NASA Glenn Research Center

POSTED

DEADLINE

Pioneering Aerospace Capabilities, Engineering and Research

Solicitation # FA2391-23-S-2403

The Pioneering Aerospace Capabilities, Engineering and Research (PACER) program, under solicitation FA2391-23-S-2403, is a comprehensive Broad Agency Announcement issued by the Air Force Research Laboratory (AFRL) Aerospace Systems Directorate. This initiative utilizes a two-step open BAA and BAA with Calls to fund research and development efforts aimed at maturing novel aerospace concepts and technologies to appropriate technology readiness levels. The program encompasses a wide array of specialized projects, including hypersonic weapon concepts (HAMWC), automated air-to-air refueling (CRONUS), advanced propulsion and power systems (SNAPP, AEPO, MSIPPT, INNATE, HITEMP), and multidisciplinary design and structures research (MASTR, VOLARE, CC DROIDS). The program employs various contract vehicles, including IDIQ contracts with CPFF or FFP task orders and Cooperative Agreements, with some individual calls featuring program ceilings up to 500 million dollars. Awards are based on peer or scientific review, focusing on technical innovation, soundness of approach, and transition potential, with cost realism serving as a secondary factor. Due to the sensitive nature of the research, offerors must adhere to strict security protocols, including AFRLI 61-113 S&T Protection guidelines, CMMC Level 2 self-assessments, and NIST SP 800-171 compliance for access to Controlled Unclassified Information (CUI) and classified data. Administrative requirements mandate that proposals be submitted in separate technical and cost volumes via DoD SAFE, with specific formatting and page limits tailored to each call. Contractors are required to use the Wide Area Workflow (WAWF) system for invoicing and must comply with rigorous packaging and marking standards, such as MIL-STD-129 and MIL-STD-130. The BAA remains open for submissions until May 10, 2043, providing a long-term framework for pioneering transformative aerospace technologies for the warfighter.

FA2391 USAF Afmc Afrl Pzl Afrl Rqkp

POSTED

DEADLINE

in over 4 years

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)The National Institute on Alcohol Abuse and Alcoholism, under the Department of Health and Human Services, intends to issue a Notice of Funding Opportunity to continue the Collaborative Initiative on Fetal Alcohol Spectrum Disorders. This multidisciplinary research consortium focuses on a wide range of studies, including basic, clinical, translational, diagnostic, intervention, and prevention research aimed at addressing the lifelong physical, cognitive, and behavioral impairments caused by prenatal alcohol exposure. The program seeks to support high-priority needs such as improving early identification and diagnosis, validating interventions, and exploring the mechanisms of alcohol teratogenesis to reduce the incidence of these disorders. Successful projects must demonstrate strong integration with the broader consortium through the use of shared resources, coordinated data activities, and multidisciplinary expertise. This forecast indicates a research program where clinical trials are optional.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Centers for Research on Neglected Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is establishing the Centers for Research on Neglected Infectious Diseases to combat communicable viral, bacterial, parasitic, and fungal infections. This initiative focuses on the epidemiology, pathogenesis, diagnosis, treatment, and prevention of parasitic neglected infectious diseases within endemic regions. By building sustainable in-country research capacity and expertise, the program aims to identify, contain, and mitigate these diseases at their source to protect global health and reduce the risk of spread within the United States. This opportunity is issued as a forecast by the Department of Health and Human Services and is governed by the Public Health Service Act and Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Interested parties can coordinate with the Division of Microbiology and Infectious Diseases for further information. The program emphasizes a multidisciplinary approach to research and training to address the substantial morbidity and mortality associated with understudied infectious diseases.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)The National Institutes of Health, under the Department of Health and Human Services, is offering a Phased Innovation Award to advance innovative HIV prevention interventions. This funding opportunity utilizes a two-stage R61/R33 structure to move research from initial development and feasibility testing to larger-scale efficacy and implementation studies. The initial R61 phase focuses on the development, refinement, and pilot testing of novel strategies to address critical scientific and operational questions, ensuring readiness for expanded evaluation across diverse populations. Upon the successful completion of R61 milestones, the R33 phase provides support for expanded testing of interventions and implementation strategies. These studies may evaluate the scalability, sustainability, and clinical management of HIV prevention interventions, specifically including integrated approaches that address alcohol use and related comorbidities. Interested parties can contact the HIV/AIDS and Alcohol Research Program for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. This initiative provides funding for the creation of book-length manuscripts and other integrative scholarly works, such as critical reviews and analytical syntheses, designed to benefit U.S. health professionals, scientists, and public health practitioners. The primary goal is to organize and disseminate biomedical and health-related knowledge to improve research, education, and clinical practice. This opportunity is listed as a forecast with a posted date of September 24, 2026. It specifically prohibits the use of clinical trials. Interested parties can contact the NLM Extramural Programs office for further information regarding the application process and program requirements.

Book Publishers

POSTED

DEADLINE

Partnerships for Advancing Development of Diagnostics for Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking to establish partnerships between academic or small business investigators and industrial partners to advance the translational development of diagnostic tests for infectious diseases. This initiative focuses on moving diagnostics that have already demonstrated proof-of-concept through the commercialization process by aligning researchers with experienced industry partners to de-risk development and ensure products are fit for purpose. The program will be supported by a science advisory board and NIAID oversight, incorporating annual meetings and workshops to facilitate collaboration and knowledge exchange. This effort is authorized under the Public Health Service Act and federal regulations to ensure that promising diagnostic technologies are successfully translated into tools for treating and preventing infectious diseases.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)The National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This initiative aims to bridge the gap between traditional clinical trial findings and real-world application by supporting collaborations on effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The program focuses on the prevention and treatment of HIV, including associated coinfections and comorbidities, across all age groups and various points of care. The goal of the program is to advance cross-cutting research in epidemiology, implementation science, and clinical, behavioral, and social sciences. This effort aligns with the broader NIH mission to implement research advances in HIV/AIDS. The opportunity is authorized under the Public Health Service Act and relevant federal regulations, with administrative oversight provided by the Division of AIDS Epidemiology Branch.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)The National Institutes of Health, under the Department of Health and Human Services, is seeking applications to establish a national network of Children's Environmental Health Research Translation Centers. These centers are designed to protect and improve children's health by developing scientific questions and public health interventions focused on translational research. A primary objective is to move evidence-informed biomedical findings into practical application for the wider community while mentoring a new generation of investigators in the field. Beyond research and translation, the program will function as a national resource to coordinate responses to emerging environmental exposures that impact children. The initiative emphasizes the creation of actionable strategies to prevent harm and ensure a healthy future for children through collaborative efforts within the environmental health community.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

The Role of the Innate Immune System in the Pathogenesis of Type 1 DiabetesThe National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting a grant opportunity to investigate the role of the innate immune system in the initiation of Type 1 Diabetes. Funded by the Special Statutory Funding Program for Type 1 Diabetes Research, this initiative seeks to identify genetic and environmental causes of the disease by examining how innate immune components interact with beta cells and pancreatic tissues. The program emphasizes the use of new approach methodologies to determine the timing and impact of environmental triggers that activate these immune pathways. The primary objective is to improve the early identification of high-risk individuals and develop future prevention and therapeutic strategies. This effort is conducted under the authority of the Public Health Service Act and relevant federal regulations. Interested parties can contact the RISP-T1D point of contact for further information regarding this forecast.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to support scientific research using data from intermediate-size patient population expanded access protocols for Amyotrophic Lateral Sclerosis (ALS). To be eligible, protocols must provide access to an investigational drug or biological product for individuals with ALS and generate data that supports research into the prevention, diagnosis, mitigation, treatment, or cure of the disease. Research goals may include analyzing the effects of products on biomarkers, target engagement, safety and outcome information such as survival and hospitalization, or general patient experience data. This opportunity is currently listed as a forecast by the National Institutes of Health under the Department of Health and Human Services, and applications are not being solicited at this time. The notice serves as a preliminary announcement to allow potential applicants sufficient time to develop responsive projects. Interested parties can contact the ALS Program for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS